

Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement
May 15, 2024
Jonathan Afilalo, an expert in osteosarcopenia and its effects on older adults, delves into the critical role of frailty assessments in patients undergoing transcatheter aortic valve replacement (TAVR). He advocates for objective testing over subjective methods to enhance patient evaluations. The concept of osteosarcopenia is introduced, emphasizing the integration of muscle and bone health in frailty assessments. Afilalo also discusses how AI advancements in CT scans improve body composition evaluation, and he highlights the significant impact of osteosarcopenia on mortality rates in older TAVR patients.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 4min
Advocating for Objective Frailty Assessments in TAVR Patients
03:48 • 2min
Defining Osteosarcopenia: Integrating Muscle and Bone Health in Frailty Assessment
05:53 • 4min
Advancements in AI for Body Composition Assessment in TAVR Patients
09:31 • 2min
Osteosarcopenia and TAVR Outcomes
11:18 • 12min